Pfizer CEO Albert Bourla Predicts China as Major Competitor by 2030 Amid Geopolitical Shifts
Trendline

Pfizer CEO Albert Bourla Predicts China as Major Competitor by 2030 Amid Geopolitical Shifts

What's Happening? Pfizer CEO Albert Bourla forecasts that China will emerge as the company's primary competitor by 2030, surpassing traditional Western pharmaceutical rivals. Speaking at the Jefferies Global Healthcare Conference in London on November 17, Bourla highlighted China's ambition to becom
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.